Skip to content
中文产业新闻精选评分76Chinese source

FDA批准百济神州泽尼达妥单抗联合替雷利珠单抗及化疗用于HER2阳性胃食管腺癌一线治疗

首个！百济神州双抗单抗组合在美国获批上市

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.